Male Breast Cancer Completed Phase 1 Trials for Trastuzumab (DB00072)

Back to Male Breast Cancer

Also known as: Breast Cancer, Male / Breast Cancer - Male / Breast cancer male / Cancer of male breast / Malignant neoplasm of male breast (disorder) / Carcinoma of male breast (disorder) / Breast cancer male NOS

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02060253
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerTreatment
NCT00028535
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsTreatment
NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment